Tom Jg Gevers

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. doi Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data
    Tom J G Gevers
    Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    Gastroenterology 145:357-65.e1-2. 2013
  2. pmc Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease
    Tom J G Gevers
    Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    BMC Nephrol 13:17. 2012

Detail Information

Publications2

  1. doi Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data
    Tom J G Gevers
    Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    Gastroenterology 145:357-65.e1-2. 2013
    ..5%-5.9%, compared with placebo. However, the effects of SA therapy vary among individuals. We collected data from individual patients with PLD to identify subgroups that benefit most from SA therapy...
  2. pmc Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease
    Tom J G Gevers
    Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
    BMC Nephrol 13:17. 2012
    ..The RESOLVE trial aims to assess the efficacy of lanreotide treatment in ADPKD patients with symptomatic polycystic livers. In this study we present the design of the RESOLVE trial...